Archive for November 2011
Radiotherapy After Breast Cancer Surgery
Wednesday, October 19, 2011, has been published in The Lancet Medical Journal, a study that will benefit radisi therapy significantly reduced the re-emergence of cancer after breast cancer surgery as much as half a chance in the next 10 years and is able to reduce the risk of dying from breast cancer with a ratio of 1:6 in 15 years.
The study, led by Professor Sarah Darby of the Clinical Trial Service Unit at Oxford University, England, this directly also found no significant difference between women who did or who did not receive radiation with a death rate from diseases other than breast cancer, as had presented in an earlier study said that radiation for breast cancer can harm the heart and increase the risk of women dying from a heart attack. This is because the technique has been increasing over the last few years avoiding exposure of the heart and lungs to radiation, so no need for such worries.
This study represents the largest study of the effect of radiotherapy in women who’ve had surgery “breast-conserving” or simply take part without taking the overall breast cancer patients by analyzing clinical trial data involving more than 10,000 women over a period of ten years to 20 years.
Can be seen clearly reduced cancer recurrence in the first year after radiotherapy and lasted for the first decade. After 10 years diagnosed with breast cancer, 35% of women who do not perform radiotherapy will experience reappearance of their cancer will. In contrast to those who underwent radiotherapy only 19% experienced a recurrence.
Quickness of a long time to see the emergence of effects of radiotherapy to death in patients with breast cancer, in 15 years shows that 25% of women who did not receive radiation therapy had died compared with 21% mortality rate in patients receiving radiotherapy. So the bottom line is that radiotherapy did not provide any impact on mortality in patients with breast cancer.
Induction Chemotherapy Drugs Direct
A new hope in treating patients with breast cancer with fewer side effects, stated yesterday the day Wednesday, October 26 in a report published in the journal Science Translational Medicine. This report is based on research conducted by scientists at Johns Hopkins Kimmel Cancer Center, Baltimore, United States of more than 17 women with breast cancer.
Research using new methods of incorporating chemotherapy drugs directly through the patient’s nipple, giving positive results in drug effectiveness against tumors early levels, pre-cancerous cells, and did not give any negative impacts such as those often produced in the methods of previous chemotherapy.
This method is designed to deliver chemotherapy drugs directly into the breast tissue, which has a branching system of milk ducts in the breast such as tree roots, so the drugs can be directly localized to the area without affecting other tissues as they did on the method of injecting the drug in the bloodstream or by the method of taking the medicine.
Thus the drug may work in its proper place is in the breast alone, without any adverse impact on other networks that do not require the drug. Dr. Vered Stearns as co-director of this study also showed evidence of at least the concentration of drug that is inserted directly into the breast in the blood stream.
The study, originally tested in mice also showed that 10 of the 14 mice injected chemotherapy drugs directly, is capable of eliminating tumors in their breast tissue and even demonstrated the effectiveness of the drug in preventing tumors in breast tissue develops in the other.
As reported by ABCNews, “The whole system into a clean breast tissue from cancer cells either visible or not.” Reveal a cancer biologist who is included in the research team. “So this method is not only cure but also prevention of cancer.”
Although the research is still arguably the early stages, but this method is considered to contribute further in treating breast cancer patients, especially those still in their infancy. Penginduksian do not rule out other cancer drugs directly to see the overall Traffic kill cancer without having a longer process of removal of the breast in women with breast cancer.
Improving Quality of EQ Sleeping With Baby with Mother
A recent study suggested the child to sleep with their mothers from birth until the age of 4 years. The study, fronted by Dr Nills Bergman from the University of Cape Town, South Africa explain about optimal development in baby’s brain and heart, thereby necessitating newborns up to one week early to sleep on the mother’s chest.
He also advocated after a week, the baby should remain close to his mother until age 3 and even 4 years as a key to the development of social intelligence and emotional quotient (EQ) is a perfect baby’s brain.
Based on observations on 16 infants while they slept, visible difference between those who sleep in bed with a sleeping baby alone with her mother. This difference suggests that babies who sleep on their own experience cardiac stress three times larger. Even the pattern looks more disturbed sleep when they sleep alone, where it affects their brain development caused by stress hormones.
Dr. Bergman also revealed that the bed itself, will not affect the good relationship between mother and child, which will affect the behavior that is not good during adolescence as well as the reduced ability of the brain in relationships with others in the future.
This research was supported by the results of previous studies that discuss the relationship of stress and sleep deprivation in animals, bringing in behavioral problems in adolescence. But on the other hand, many experts are still worried about the safety of infants who sleep with the mother at risk of dying from lack of movement sengajaan mother while asleep.